Psilocybin Treatment in Advanced-Stage Cancer Patients With Anxiety: (609412010-001)
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Cited by
Sorted by citations
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression
Goodwin, G. M., Aaronson, S. T., Alvarez, O., Arden, P. C., Baker, A., Bennett, J. C., Bird, C., Blom, R. E., Brennan, C., Brusch, D., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2206443 · Cited by 1,167 · see citing works
- Authors
- Grob, C. S.
- Corresponding author
- Grob, Charles S.
- Venue
- PsycEXTRA Dataset
- Published
- 2010
- OpenAlex
- W4230492997
- Cited by
- 0
- References
- 0
- Type
- dataset
- Language
- en
- Open access
- closed
- Locations
- PsycEXTRA Dataset (publishedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Social Sciences › Health › Religion, Spirituality, and Psychology
- Keywords
- psilocybin, advanced cancer, anxiety, psychedelic therapy, cancer patients
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
